Source: Eur Respir Monogr 2012; 58: 111-123
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Kai Kliiman, Gunar Günther, Alan Altraja. TB drug resistance in low-incidence countries. Eur Respir Monogr 2012; 58: 111-123

Member's Comments

No comment yet.

Related content which might interest you: Drug resistance and tuberculosis elimination in low-incidence countries Source: Eur Respir J 2014; 44: 1408-1411 Year: 2014 TB drug resistance in high-incidence countries Source: Eur Respir Mon 2012; 58: 95-110 Year: 2012 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission Source: Eur Respir J 2006; 28: Suppl. 50, 290s Year: 2006 The association between HIV and antituberculosis drug resistance Source: Eur Respir J 2008; 32: 718-725 Year: 2008 Towards tuberculosis elimination: an action framework for low-incidence countries Source: Eur Respir J 2015; 45: 928-952 Year: 2015 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia Source: Eur Respir J 2012; 40: 133-142 Year: 2012 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Tuberculosis screening in migrants in selected European countries shows wide disparities Source: Eur Respir J 2006; 27: 801-807 Year: 2006 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country Source: Eur Respir J, 57 (6) 2002544; 10.1183/13993003.02544-2020 Year: 2021 Molecular surveillance of multi-drug resistant tuberculosis in Europe Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Mycobacterium tuberculosis drug resistance surveillance in Belarus Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005 Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Towards selective tuberculosis screening of people in prison in a low-incidence country Source: Eur Respir J, 55 (4) 1902209; 10.1183/13993003.02209-2019 Year: 2020 Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Comparison of tuberculosis surveillance systems in low-incidence industrialised countries Source: Eur Respir J 2008; 32: 1616-1624 Year: 2008 Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007 Trend in TB control in Republic of Moldova: High MDRTB burden country Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014